Design Therapeutics's total assets for Q3 2025 were $211.77M, a decrease of -4.99% from the previous quarter. DSGN total liabilities were $12.05M for the fiscal quarter, a 22.35% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.